ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 137

Monosodium Urate Crystals Inhibit Tenocyte Viability and Function: Implications for Periarticular Involvement in Chronic Gout

Ashika Chhana1, Karen E. Callon1, Bregina Pool1, Dorit Naot1, Gregory Gamble2, Brendan Coleman3, Fiona M. McQueen4, Jillian Cornish1 and Nicola Dalbeth1, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3Orthopedic Surgery, Middlemore Hospital, Auckland, New Zealand, 4Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cell biology and gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recent advanced imaging studies have demonstrated that urate deposition in periarticular structures is common in gout. Urate deposition has been observed both adjacent to and within tendons, suggesting that monosodium urate monohydrate (MSU) crystals are likely to be in direct contact with tenocytes, the stromal cells of tendons.  The aim of this study was to determine the effects of MSU crystals on tenocyte viability and function.   

Methods: Cultures of primary rat tenocytes were prepared from Wistar rat tails. Primary human tenocytes were prepared from patients undergoing orthopedic surgery. MTT assays were used to assess tenocyte viability following culture with MSU crystals.  Cells cultured with MSU crystals for various times were stained with Annexin V and propidium iodide, and flow cytometry was used to determine changes in the levels of apoptosis.  Real-time PCR was used to determine changes in gene expression and Sirius red staining to detect changes in collagen deposition in tenocytes cultured with MSU crystals. 

Results: MSU crystals reduced viability in a dose-dependent manner in both primary rat and human tenocytes (Figure).  Differing MSU crystal lengths and increased serum levels in cultures did not alter this effect.  The reduction in tenocyte viability was specific to MSU crystals, as soluble uric acid did not reduce cell viability.  Flow cytometry showed that MSU crystals rapidly induced cell death, but apoptosis levels remained unchanged.  Culture with MSU crystals reduced mRNA expression of collagen types 1 and 3; and tenocytic markers, including tenomodulin, scleraxis and tenascin-C.  Collagen deposition was inhibited in tenocytes cultured with MSU crystals in a dose dependent manner.

Conclusion: These data indicate that MSU crystals directly interact with tenocytes to reduce cell viability and function.  These interactions may contribute to tendon damage in patients with chronic gout. 

Figure:  Effects of MSU crystals on primary rat and human tenocyte viability.  Cell viability was assessed using the MTT assay following 24 hours of culture with MSU crystals.  Data shown are mean (SEM); one-way ANOVA (P<0.0001) with post hoc Dunnett’s test *p<0.0001 versus control (no MSU crystals). 


Disclosure:

A. Chhana,
None;

K. E. Callon,
None;

B. Pool,
None;

D. Naot,
None;

G. Gamble,
None;

B. Coleman,
None;

F. M. McQueen,
None;

J. Cornish,
None;

N. Dalbeth,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/monosodium-urate-crystals-inhibit-tenocyte-viability-and-function-implications-for-periarticular-involvement-in-chronic-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology